HR Masterclass Series: High-level HR strategy training workshops
with topics ranging from Analytics, to HR Business Partnering, Coaching, Leadership, Agile Talent and more.
Review the 2020 masterclasses here »
As part of its increasing focus on Asia’s nutrition and health challenges, global specialty food ingredients and pharmaceutical excipients firm, Roquette unveiled its new Asia Pacific headquarters and an innovation centre in Singapore yesterday.
According to a media statement, the new facilities will be focused on food, nutrition and pharma to better address eating habits and health concerns of Asian consumers.
Roquette’s headcount in Singapore has grown rapidly – from 15 employees last year to around 50 now. In line with the opening of the new headquarters and innovation centre, the company expects to further increase its headcount to hit 70 to 80 in the next few years.
Jean-Marc Gilson, CEO of Roquette, said: “Our facilities in Singapore will allow us to explore new ways to address specific health and nutrition needs of Asian customers and consumers through plant-based ingredients such as sugar alternatives, vegetal proteins or pharmaceutical excipients, among many others.”
The more than 1,100 square meter innovation center is located in Biopolis and adds to Roquette’s existing presence in Asia, which includes today a large commercial presence in many countries and several sites in China, India and South Korea.
The new facilities – including a research laboratory, customer technical services as well as the new regional headquarters – will complement Roquette’s existing research and application centers in the Americas, Asia and Europe.
They will reinforce Roquette’s deep expertise to support customer innovations in food, nutrition and pharma, while allowing the company to tailor its products and address the specific health and dietary challenges of the region such as obesity or diabetes.
At the same time, this will allow the company to partner with customers, universities and research institutions, such as Singapore’s Agency for Science, Technology and Research (A*STAR) or the National University of Singapore.
On the choice of this location, Gilson noted that Singapore’s connectivity with countries throughout Asia makes it the perfect place to locate these new facilities, which will be a key part of Roquette’s global network.
He added: “The talent and skills of Singapore professionals are impressive, and our local team will make a big impact. We are looking forward to foster closer collaboration with our customers and partners as well as further develop our business activities in the region and continue to invest in Asia over the next few years.”
This announcement, follows a series of recent global investments by Roquette into North America, Latin America and Europe, and will help propel the future growth of the company’s food and pharmaceutical businesses.
Photo / Roquette